185 related articles for article (PubMed ID: 6088630)
1. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
[TBL] [Abstract][Full Text] [Related]
2. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
Bellamy AS; Calder VL; Feldmann M; Davison AN
Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.
Braakman E; van Tunen A; Meager A; Lucas CJ
Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897
[TBL] [Abstract][Full Text] [Related]
4. [Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone].
Yagi Y; Takahashi M; Nakamura Y
Rinsho Shinkeigaku; 1997 Jul; 37(7):575-9. PubMed ID: 9396353
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.
Pastorelli G; Roncarolo MG; Touraine JL; Peronne G; Tovo PA; de Vries JE
Clin Exp Immunol; 1989 Dec; 78(3):334-40. PubMed ID: 2515013
[TBL] [Abstract][Full Text] [Related]
6. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
[TBL] [Abstract][Full Text] [Related]
7. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
Elliott LH; Brooks WH; Roszman TL
J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
[TBL] [Abstract][Full Text] [Related]
8. In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosis.
Vervliet G; Schandené L
Clin Exp Immunol; 1985 Sep; 61(3):556-61. PubMed ID: 3935348
[TBL] [Abstract][Full Text] [Related]
9. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
Maimone D; Reder AT; Gregory S
Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234
[TBL] [Abstract][Full Text] [Related]
10. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Hafler DA; Fox DA; Manning ME; Schlossman SF; Reinherz EL; Weiner HL
N Engl J Med; 1985 May; 312(22):1405-11. PubMed ID: 2985995
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.
Selmaj K; Nowak Z; Tchórzewski H
Clin Exp Immunol; 1988 Jun; 72(3):428-33. PubMed ID: 2458871
[TBL] [Abstract][Full Text] [Related]
12. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
[TBL] [Abstract][Full Text] [Related]
13. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
[TBL] [Abstract][Full Text] [Related]
14. Normalization of defective interleukin 1 and interleukin 2 production in patients with pemphigus vulgaris following chrysotherapy.
Blitstein-Willinger E
Clin Exp Immunol; 1985 Dec; 62(3):705-14. PubMed ID: 3936658
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements.
Stinissen P; Vandevyver C; Medaer R; Vandegaer L; Nies J; Tuyls L; Hafler DA; Raus J; Zhang J
J Immunol; 1995 May; 154(9):4883-94. PubMed ID: 7722338
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 2 production, proliferative response, and receptor expression by cord blood mononuclear cells.
Fairfax CA; Borzy MS
J Clin Lab Immunol; 1988 Oct; 27(2):63-7. PubMed ID: 3266760
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 response to arterial antigen, lipopolysaccharide, and oxidized low density lipoprotein in ischemic heart disease.
Grasing K; Rifici V; Patel M; Patel A; Dennis R; Kostis JB
J Investig Med; 1997 Oct; 45(8):474-82. PubMed ID: 9394101
[TBL] [Abstract][Full Text] [Related]
19. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
20. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
